troxerutin chirmis 20 mg/g
tis farmaceutic sa - romania - troxerutinum - gel - 20 mg/g - medicatia capilarelor (capilarotonice) bioflavonoide
fid-mibi 1 mg
national centre for nuclear research - polonia - radiofarmaceutice - kit pt. preparat radiofarmaceutic - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
lucentis 10 mg/ml soluţie injectabilă
novartis pharma ag - ranibizumabum - soluţie injectabilă - 10 mg/ml
technescan sestamibi 1 mg
mallinckrodt medical b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
vigamox 5 mg/ml
novartis farmaceutica, s.a. - spania - moxifloxacinum - pic. oft., sol. - 5mg/ml - antiinfectioase antiinfectioase
sintocalmin 300 mg
sintofarm s.a. - romania - metamizolum de sodiu - supoz. - 300mg - alte analgezice si antipiretice pirazolone
proclorperazina sintofarm 25 mg (vezi n05ab04)
sintofarm sa - romania - prochlorperazinum - supoz. - 25mg - antipsihotice fenotiazine cu structura piperazinica
proclorperazina sintofarm 5 mg (vezi n05ab04)
sintofarm sa - romania - prochlorperazinum - supoz. - 5mg - antipsihotice fenotiazine cu structura piperazinica
technescan sestamibi 1 mg
curium netherlands b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).